Novo Nordisk’s Wegovy Approved for Obesity Treatment in India
India’s regulatory authority has officially approved the use of semaglutide, marketed by Novo Nordisk as Wegovy, for the treatment of metabolic dysfunction-associated steatohepatitis (MASH), formerly known as non-alcoholic steatohepatitis (NASH). ... Read More